Two of the 123 genetic regions corresponded to proteins targeted by migraine medications.
The expanded list of genetic regions for migraines may allow for new drugs to be identified that target those.
READ RELATED: Fatty liver disease: Stages of the disease with accompanying symptoms – how to quit
Dr Matti Pirinen, who led the study, said: “These two new associations near genes that are already targeted by effective migraine drugs suggest that there could be other potential drug targets among the new genomic regions, and provide a clear rationale for future genetic studies with even larger sample sizes.”
Source: Daily Express
